Physician profile
Raman Unnikrishnan
NPI 1831414739
$9,366.10
in general payments reported to CMS, 2019-2025
40 companies · $1,486 in 2025
The $1,486 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,038 · 2020: $233 · 2021: $277 · 2022: $294 · 2023: $1,825 · 2024: $3,212 · 2025: $1,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,209 · Travel and Lodging: $1,100 · Consulting Fee: $1,090 · Grant: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,208.52 |
| Travel and Lodging | $1,100.42 |
| Consulting Fee | $1,090.00 |
| Grant | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,486.26 | 2019-2025 | Erleada |
| Angiodynamics, INC. | $1,872.84 | 2024-2025 | Nanoknife |
| Dendreon Pharmaceuticals LLC | $733.74 | 2019-2020 | |
| Bioprotect Medical, INC. | $615.57 | 2024-2025 | Bioprotect Balloon Implant System |
| Palette Life Sciences, INC. | $522.84 | 2021-2023 | |
| Astellas Pharma US INC | $471.64 | 2019-2025 | Xtandi, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $463.86 | 2019-2025 | |
| Theragenics Corporation | $215.76 | 2025 | |
| Dornier Medtech America, INC | $175.14 | 2019 | |
| Sumitomo Pharma America, INC. | $160.17 | 2023-2025 | Orgovyx |
| Pfizer INC. | $146.86 | 2019-2025 | |
| Abbvie INC. | $125.00 | 2024 | |
| Accord Healthcare, INC. | $123.96 | 2024 | |
| Blue Earth Diagnostics | $123.79 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $103.45 | 2019-2023 | Bard Urinary Drainage Bag |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raman Unnikrishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.